Literature DB >> 8985389

Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.

Y Sagara1, C Ishida, Y Inoue, H Shiraki, Y Maeda.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) envelope proteins play an important role in viral entry into target cells. In a syncytium formation assay consisting of a coculture of HTLV-1-bearing cells and target cells, mature gp46 and gp21 proteins each inhibited syncytium formation induced by HTLV-1-bearing cells. Experiments with 125I-labeled proteins showed that 125I-gp46 bound specifically with MOLT-4 target cells even in the presence of large amounts of gp21, whereas 125I-gp21 binding to target cells was completely blocked in the presence of large amounts of gp46. These observations suggest that HTLV-1 envelope proteins in syncytium formation interact with at least two components, which are located close to each other on the cell membrane. We isolated two components from MOLT-4 cell lysate, using Sepharose 4B columns coupled with peptides corresponding to amino acids 197 to 216 and 400 to 429, respectively, of the envelope protein. One is a trypsin digestion-sensitive component of approximately 34 to 35 kDa, which interacts specifically with gp46. The other is a nonprotein component, which interacts with gp21. This component was destroyed by sodium periodate oxidation and was partitioned into the methanol-chloroform phase. These observations suggest that these two components play an important role in HTLV-1 entry into target cells via membrane fusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985389      PMCID: PMC191090     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis.

Authors:  S Jacobson; C S Raine; E S Mingioli; D E McFarlin
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

Review 2.  Viral and cellular membrane fusion proteins.

Authors:  J M White
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

3.  Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia.

Authors:  B I Sahai Srivastava; J Minowada
Journal:  Biochem Biophys Res Commun       Date:  1973-04-02       Impact factor: 3.575

4.  HTLV-I-associated myelopathy and polymyositis in a US native.

Authors:  B K Evans; I Gore; L E Harrell; T Arnold; S J Oh
Journal:  Neurology       Date:  1989-12       Impact factor: 9.910

5.  Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.

Authors:  N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

6.  Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.

Authors:  Y Sagara; Y Inoue; H Shiraki; A Jinno; H Hoshino; Y Maeda
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy.

Authors:  S Bhagavati; G Ehrlich; R W Kula; S Kwok; J Sninsky; V Udani; B J Poiesz
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

8.  Human T cell leukemia viruses use a receptor determined by human chromosome 17.

Authors:  M A Sommerfelt; B P Williams; P R Clapham; E Solomon; P N Goodfellow; R A Weiss
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

9.  Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.

Authors:  H Shida; T Tochikura; T Sato; T Konno; K Hirayoshi; M Seki; Y Ito; M Hatanaka; Y Hinuma; M Sugimoto
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

10.  Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: cytoplasmic continuity and lipid mixing.

Authors:  D P Sarkar; S J Morris; O Eidelman; J Zimmerberg; R Blumenthal
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  5 in total

1.  Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions.

Authors:  Kathryn S Jones; Manisha Nath; Cari Petrow-Sadowski; Andrea C Baines; Megan Dambach; Ying Huang; Francis W Ruscetti
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Koichi Ohshima; Tadashi Matsumoto; Masao Matsuoka
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

3.  71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.

Authors:  Y Sagara; C Ishida; Y Inoue; H Shiraki; Y Maeda
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.

Authors:  A Jinno; Y Haraguchi; H Shiraki; H Hoshino
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.

Authors:  Josefina D Piñon; P J Klasse; Sushma R Jassal; Sandy Welson; Jonathan Weber; David W Brighty; Quentin J Sattentau
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.